Does CENEGERMIN-BKBJ Cause Product dose omission issue? 1,335 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,335 reports of Product dose omission issue have been filed in association with CENEGERMIN-BKBJ. This represents 11.2% of all adverse event reports for CENEGERMIN-BKBJ.
1,335
Reports of Product dose omission issue with CENEGERMIN-BKBJ
11.2%
of all CENEGERMIN-BKBJ reports
9
Deaths
125
Hospitalizations
How Dangerous Is Product dose omission issue From CENEGERMIN-BKBJ?
Of the 1,335 reports, 9 (0.7%) resulted in death, 125 (9.4%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CENEGERMIN-BKBJ. However, 1,335 reports have been filed with the FAERS database.
What Other Side Effects Does CENEGERMIN-BKBJ Cause?
Eye pain (5,847)
Eye irritation (1,871)
Ocular hyperaemia (1,226)
Photophobia (1,065)
Vision blurred (944)
Wrong technique in product usage process (899)
Eye swelling (847)
Ocular discomfort (797)
Lacrimation increased (737)
Eyelid pain (707)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which CENEGERMIN-BKBJ Alternatives Have Lower Product dose omission issue Risk?
CENEGERMIN-BKBJ vs CENOBAMATE
CENEGERMIN-BKBJ vs CEPHALEXIN
CENEGERMIN-BKBJ vs CERITINIB
CENEGERMIN-BKBJ vs CERLIPONASE ALFA
CENEGERMIN-BKBJ vs CERTICAN